Home > > > Report Detail

Global Hepatitis B and C Diagnostics Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 16-Jul-2019
No. of pages: 102
Inquire Before Buying

Hepatitis B diagnostic tests include HBV serologic tests, molecular deoxyribonucleic acid (DNA) tests, histology tests, and laboratory tests. HBV serologic tests involve the measurement of antigens and antibodies. Hepatitis C diagnostic tests include anti-HCV serologic test, HCV recombinant immunoblot assay (RIBA) antibody test, and HCV molecular ribonucleic acid (RNA) testing. Anti-HCV is the serologic test used for screening.

The increasing demand for molecular diagnostic of HBV (hepatitis B virus) and HCV (hepatitis C virus) infections is one of the primary drivers for the growth of this market. Molecular diagnosis simplifies sample preparation for high-volume testing and includes identification and profiling of causative agents of infection and the quantification of pathogens to monitor durability of therapy; thus, resulting in sales of around 60% of the overall molecular diagnosis market. Additionally, new companies are also focusing on the development of new products, which, in turn, is expected to change market dynamics for the diagnosis of HBV and HCV infections. For instance, Cepheid recently announced a quantitative test that offers on-demand molecular testing for confirmation of infection and monitoring of HCV and has obtained CE-IVD (in vitro diagnostics) status under the European Directive on in-vitro diagnostic medical devices, making it one of the leading platforms for molecular diagnosis.

Increasing incidence of HBV and HCV infections in the Americas will contribute to the growth of the diagnostic market. The Americas will dominate the market, accounting for half of the total market share by 2023. The recent increase in blood transfusion will result in the adoption of third-generation hepatitis C diagnostic tests like HCV enzyme immunoassay that contribute to the growth of the market in this region. Also, the implementation of biomarker-based POC (point-of-care) tests initiated by the government and non-profit organizations, is also expected to drive the market growth as the products are highly accessible and easy to use.

In 2018, the global Hepatitis B and C Diagnostics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hepatitis B and C Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hepatitis B and C Diagnostics development in United States, Europe and China.

The key players covered in this study

- Roche Diagnostics

- Abbott

- Siemens

- Qiagen

- Alere

- bioMérieux

- Cepheid

- Chembio Diagnostics

- DiaSorin

- Enzo Life Sciences

- Hologic

- MedMira

- OraSure Technologies

- Quest Diagnostics

- Quidel Corp

- Randox Laboratories

Market segment by Type, the product can be split into

- Hepatitis B

- Hepatitis C

Market segment by Application, split into

- Immunodiagnostics

- Nucleic Acid Test (NAT)

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Hepatitis B and C Diagnostics status, future forecast, growth opportunity, key market and key players.

- To present the Hepatitis B and C Diagnostics development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hepatitis B and C Diagnostics are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Hepatitis B and C Diagnostics Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type (2014-2025)
1.4.2 Hepatitis B
1.4.3 Hepatitis C
1.5 Market by Application
1.5.1 Global Hepatitis B and C Diagnostics Market Share by Application (2014-2025)
1.5.2 Immunodiagnostics
1.5.3 Nucleic Acid Test (NAT)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Hepatitis B and C Diagnostics Market Size
2.2 Hepatitis B and C Diagnostics Growth Trends by Regions
2.2.1 Hepatitis B and C Diagnostics Market Size by Regions (2014-2025)
2.2.2 Hepatitis B and C Diagnostics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Hepatitis B and C Diagnostics Market Size by Manufacturers
3.1.1 Global Hepatitis B and C Diagnostics Revenue by Manufacturers (2014-2019)
3.1.2 Global Hepatitis B and C Diagnostics Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hepatitis B and C Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2 Hepatitis B and C Diagnostics Key Players Head office and Area Served
3.3 Key Players Hepatitis B and C Diagnostics Product/Solution/Service
3.4 Date of Enter into Hepatitis B and C Diagnostics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Hepatitis B and C Diagnostics Market Size by Type (2014-2019)
4.2 Global Hepatitis B and C Diagnostics Market Size by Application (2014-2019)
5 United States
5.1 United States Hepatitis B and C Diagnostics Market Size (2014-2019)
5.2 Hepatitis B and C Diagnostics Key Players in United States
5.3 United States Hepatitis B and C Diagnostics Market Size by Type
5.4 United States Hepatitis B and C Diagnostics Market Size by Application
6 Europe
6.1 Europe Hepatitis B and C Diagnostics Market Size (2014-2019)
6.2 Hepatitis B and C Diagnostics Key Players in Europe
6.3 Europe Hepatitis B and C Diagnostics Market Size by Type
6.4 Europe Hepatitis B and C Diagnostics Market Size by Application
7 China
7.1 China Hepatitis B and C Diagnostics Market Size (2014-2019)
7.2 Hepatitis B and C Diagnostics Key Players in China
7.3 China Hepatitis B and C Diagnostics Market Size by Type
7.4 China Hepatitis B and C Diagnostics Market Size by Application
8 Japan
8.1 Japan Hepatitis B and C Diagnostics Market Size (2014-2019)
8.2 Hepatitis B and C Diagnostics Key Players in Japan
8.3 Japan Hepatitis B and C Diagnostics Market Size by Type
8.4 Japan Hepatitis B and C Diagnostics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Hepatitis B and C Diagnostics Market Size (2014-2019)
9.2 Hepatitis B and C Diagnostics Key Players in Southeast Asia
9.3 Southeast Asia Hepatitis B and C Diagnostics Market Size by Type
9.4 Southeast Asia Hepatitis B and C Diagnostics Market Size by Application
10 India
10.1 India Hepatitis B and C Diagnostics Market Size (2014-2019)
10.2 Hepatitis B and C Diagnostics Key Players in India
10.3 India Hepatitis B and C Diagnostics Market Size by Type
10.4 India Hepatitis B and C Diagnostics Market Size by Application
11 Central & South America
11.1 Central & South America Hepatitis B and C Diagnostics Market Size (2014-2019)
11.2 Hepatitis B and C Diagnostics Key Players in Central & South America
11.3 Central & South America Hepatitis B and C Diagnostics Market Size by Type
11.4 Central & South America Hepatitis B and C Diagnostics Market Size by Application
12 International Players Profiles
12.1 Roche Diagnostics
12.1.1 Roche Diagnostics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hepatitis B and C Diagnostics Introduction
12.1.4 Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.1.5 Roche Diagnostics Recent Development
12.2 Abbott
12.2.1 Abbott Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hepatitis B and C Diagnostics Introduction
12.2.4 Abbott Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.2.5 Abbott Recent Development
12.3 Siemens
12.3.1 Siemens Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hepatitis B and C Diagnostics Introduction
12.3.4 Siemens Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.3.5 Siemens Recent Development
12.4 Qiagen
12.4.1 Qiagen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hepatitis B and C Diagnostics Introduction
12.4.4 Qiagen Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.4.5 Qiagen Recent Development
12.5 Alere
12.5.1 Alere Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hepatitis B and C Diagnostics Introduction
12.5.4 Alere Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.5.5 Alere Recent Development
12.6 bioMérieux
12.6.1 bioMérieux Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hepatitis B and C Diagnostics Introduction
12.6.4 bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.6.5 bioMérieux Recent Development
12.7 Cepheid
12.7.1 Cepheid Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hepatitis B and C Diagnostics Introduction
12.7.4 Cepheid Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.7.5 Cepheid Recent Development
12.8 Chembio Diagnostics
12.8.1 Chembio Diagnostics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hepatitis B and C Diagnostics Introduction
12.8.4 Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.8.5 Chembio Diagnostics Recent Development
12.9 DiaSorin
12.9.1 DiaSorin Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hepatitis B and C Diagnostics Introduction
12.9.4 DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.9.5 DiaSorin Recent Development
12.10 Enzo Life Sciences
12.10.1 Enzo Life Sciences Company Details
12.10.2 Company Description and Business Overview
12.10.3 Hepatitis B and C Diagnostics Introduction
12.10.4 Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2014-2019)
12.10.5 Enzo Life Sciences Recent Development
12.11 Hologic
12.12 MedMira
12.13 OraSure Technologies
12.14 Quest Diagnostics
12.15 Quidel Corp
12.16 Randox Laboratories
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Hepatitis B and C Diagnostics Key Market Segments
Table Key Players Hepatitis B and C Diagnostics Covered
Table Global Hepatitis B and C Diagnostics Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Hepatitis B and C Diagnostics Market Size Market Share by Type 2014-2025
Figure Hepatitis B Figures
Table Key Players of Hepatitis B
Figure Hepatitis C Figures
Table Key Players of Hepatitis C
Table Global Hepatitis B and C Diagnostics Market Size Growth by Application 2014-2025 (Million US$)
Figure Immunodiagnostics Case Studies
Figure Nucleic Acid Test (NAT) Case Studies
Figure Hepatitis B and C Diagnostics Report Years Considered
Table Global Hepatitis B and C Diagnostics Market Size 2014-2025 (Million US$)
Figure Global Hepatitis B and C Diagnostics Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Hepatitis B and C Diagnostics Market Size by Regions 2014-2025 (Million US$)
Table Global Hepatitis B and C Diagnostics Market Size by Regions 2014-2019 (Million US$)
Table Global Hepatitis B and C Diagnostics Market Share by Regions 2014-2019
Figure Global Hepatitis B and C Diagnostics Market Share by Regions 2014-2019
Figure Global Hepatitis B and C Diagnostics Market Share by Regions 2019
Table Market Top Trends
Table Global Hepatitis B and C Diagnostics Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Hepatitis B and C Diagnostics Market Share by Manufacturers (2014-2019)
Figure Global Hepatitis B and C Diagnostics Market Share by Manufacturers in 2018
Table Global Hepatitis B and C Diagnostics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Hepatitis B and C Diagnostics Product/Solution/Service
Table Date of Enter into Hepatitis B and C Diagnostics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Global Hepatitis B and C Diagnostics Market Size Share by Type (2014-2019)
Figure Global Hepatitis B and C Diagnostics Market Size Market Share by Type (2014-2019)
Table Global Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Global Hepatitis B and C Diagnostics Market Size Share by Application (2014-2019)
Figure Global Hepatitis B and C Diagnostics Market Size Market Share by Application (2014-2019)
Figure Global Hepatitis B and C Diagnostics Revenue Market Share by Application in 2018
Figure United States Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table United States Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table United States Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table United States Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table United States Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table United States Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table United States Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure Europe Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table Europe Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table Europe Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table Europe Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Europe Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table Europe Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Europe Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure China Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table China Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table China Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table China Hepatitis B and C Diagnostics Market Size by Type (2014-20189) (Million US$)
Table China Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table China Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table China Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure Japan Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table Japan Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table Japan Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table Japan Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Japan Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table Japan Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Japan Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure Southeast Asia Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table Southeast Asia Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table Southeast Asia Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure India Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table India Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table India Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table India Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table India Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table India Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table India Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Figure Central & South America Hepatitis B and C Diagnostics Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Hepatitis B and C Diagnostics Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Hepatitis B and C Diagnostics Market Share (2018-2019)
Table Central & South America Hepatitis B and C Diagnostics Market Size by Type (2014-2019) (Million US$)
Table Central & South America Hepatitis B and C Diagnostics Market Share by Type (2014-2019)
Table Central & South America Hepatitis B and C Diagnostics Market Size by Application (2014-2019) (Million US$)
Table Central & South America Hepatitis B and C Diagnostics Market Share by Application (2014-2019)
Table Roche Diagnostics Company Details
Table Roche Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2014-2019) (Million US$)
Figure Roche Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Roche Diagnostics Recent Development
Table Abbott Company Details
Table Abbott Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Abbott Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Abbott Recent Development
Table Siemens Company Details
Table Siemens Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Siemens Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Siemens Recent Development
Table Qiagen Company Details
Table Qiagen Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Qiagen Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Qiagen Recent Development
Table Alere Company Details
Table Alere Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Alere Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Alere Recent Development
Table bioMérieux Company Details
Table bioMérieux Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure bioMérieux Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table bioMérieux Recent Development
Table Cepheid Company Details
Table Cepheid Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Cepheid Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Cepheid Recent Development
Table Chembio Diagnostics Company Details
Table Chembio Diagnostics Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Chembio Diagnostics Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Chembio Diagnostics Recent Development
Table DiaSorin Company Details
Table DiaSorin Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure DiaSorin Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table DiaSorin Recent Development
Table Enzo Life Sciences Company Details
Table Enzo Life Sciences Revenue in Hepatitis B and C Diagnostics Business (2014-2019)(Million US$)
Figure Enzo Life Sciences Revenue Growth Rate in Hepatitis B and C Diagnostics Business (2014-2019)
Table Enzo Life Sciences Recent Development
Table Hologic Company Details
Table MedMira Company Details
Table OraSure Technologies Company Details
Table Quest Diagnostics Company Details
Table Quidel Corp Company Details
Table Randox Laboratories Company Details
Table Global Hepatitis B and C Diagnostics Market Size by Regions (Million US$) 2019-2025
Figure Global Hepatitis B and C Diagnostics Market Size Share by Regions (2019-2025)
Figure Global Hepatitis B and C Diagnostics Market Size Share by Regions in 2025
Figure United States Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Europe Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure China Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Japan Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure India Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Hepatitis B and C Diagnostics Market Size Forecast (2019-2025)(Million USD)
Table Global Hepatitis B and C Diagnostics Market Size by Product (2019-2025) (Million US$)
Figure Global Hepatitis B and C Diagnostics Market Size by Product (2019-2025)
Figure Global Hepatitis B and C Diagnostics Market Size by Product in 2025
Table Global Hepatitis B and C Diagnostics Market Size by Application (2019-2025) (Million US$)
Figure Global Hepatitis B and C Diagnostics Market Size by Application (2019-2025)
Figure Global Hepatitis B and C Diagnostics Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs